H2 antagonists

3138 WPI Pill - brown capsule-shape, 22mm

Pill with imprint 3138 WPI is Brown, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of GERD; Erosive Esophagitis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Stomach Ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Nizatidine (Nizatidine [ ni-za-ti-deen ])-3138 WPI-300 mg-Brown-Capsule-shape

Nizatidine
Generic Name: nizatidine [ ni-za-ti-deen ]
Imprint: 3138 WPI
Strength: 300 mg
Color: Brown
Size: 22.00 mm
Shape: Capsule-shape
Availability: Rx and/or OTC
Drug Class: H2 antagonists
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00591-3138
Inactive Ingredients: Silicon dioxide, Corn starch, Croscarmellose sodium, Magnesium stearate, Ammonia, Ferrosoferric oxide, Gelatin, Potassium hydroxide, Propylene glycol, Shellac, Sodium lauryl sulfate, Titanium dioxide, Ferric oxide red, Ferric oxide yellow,
Latest News
Related Drugs